title: Has the time come for biotherapies in giant cell arteritis and polymyalgia rheumatica?
authors.affiliation: Département de rhumatologie, hôpital de la Cavale-Blanche, 29609 Brest, France; EA2216, INSERM ESPRI, ERI29, université de Brest, LabEx IGO, 29609 Brest, France. Electronic address: valerie.devauchelle-pensec@chu-brest.fr.
authors.forename: Valérie
authors.initials: V
authors.lastname: Devauchelle-Pensec
mesh_terms: D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D001691:Biological Therapy; D005260:Female; D013700:Giant Cell Arteritis / Q000276:immunology / Q000628:therapy*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D011111:Polymyalgia Rheumatica / Q000628:therapy*; D000093242:Interleukin-6 Inhibitors
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D005938:Glucocorticoids; D000093242:Interleukin-6 Inhibitors; C502936:tocilizumab
keywords: Corticosteroid; Giant cell arteritis; Interleukin-6; Polymyalgia rheumatica; Tocilizumab